Live Breaking News & Updates on Director Yann Echelard
Stay updated with breaking news from Director yann echelard. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
TG Therapeutics, Inc. (NASDAQ:TGTX – Get Rating)’s share price traded up 7.6% during mid-day trading on Monday . The stock traded as high as $16.22 and last traded at $16.19. 1,867,523 shares changed hands during mid-day trading, a decline of 57% from the average session volume of 4,388,624 shares. The stock had previously closed at […] ....
HC Wainwright reaffirmed their buy rating on shares of TG Therapeutics (NASDAQ:TGTX – Get Rating) in a research note released on Friday morning, Benzinga reports. The firm currently has a $24.00 target price on the biopharmaceutical company’s stock. TGTX has been the topic of several other research reports. Bank of America upped their price objective […] ....
TG Therapeutics, Inc. (NASDAQ:TGTX – Get Rating) traded up 7.6% during mid-day trading on Monday . The company traded as high as $16.22 and last traded at $16.19. 1,867,523 shares were traded during trading, a decline of 57% from the average session volume of 4,388,624 shares. The stock had previously closed at $15.04. Analyst Upgrades […] ....
TG Therapeutics (NASDAQ:TGTX – Get Rating)‘s stock had its “buy” rating reiterated by investment analysts at HC Wainwright in a report issued on Friday, Benzinga reports. They currently have a $24.00 price objective on the biopharmaceutical company’s stock. HC Wainwright’s target price indicates a potential upside of 64.61% from the stock’s previous close. Several other […] ....
TG Therapeutics, Inc. (NASDAQ:TGTX – Get Rating) – Equities researchers at HC Wainwright dropped their Q1 2023 EPS estimates for TG Therapeutics in a research note issued on Wednesday, March 1st. HC Wainwright analyst E. White now forecasts that the biopharmaceutical company will earn ($0.36) per share for the quarter, down from their previous estimate […] ....